Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accommodate, Appendix, Arbitrage, ASC, authoritative, Avastin, bid, Bureau, cautionary, CHMP, Codification, Compensationand, cured, debate, degenerative, distributor, extinguishment, fact, GAAP, incremental, indentifying, introduction, janssen, Johnson, kind, MAA, nonclinical, nongovernmental, nonstatutory, Offshore, ordinary, path, pazopanib, petition, PhD, prudent, pursuit, QP, RCC, recognizable, reform, retrospective, retrospectively, screening, Segment, slightly, strictly, Tang, Temodar, temozolomide, tolling, UCSF, undue, unrecognizable, verbally, waive, waiver, wider, Wolverine
Removed:
abundance, accomplish, adversarial, afeyan, AGTC, alleviation, amenable, analyze, announcement, apparent, Arizona, Armenia, asserted, auction, autoimmune, bachelor, Background, baseline, began, Belgium, benchmark, biomedica, biopharmaceutical, bone, bound, break, breakdown, Bulletin, calculable, capecitabine, characterize, charitable, chemical, children, COAF, College, commenced, commitment, communication, comparator, comparing, complexed, conceived, confirm, conserve, considerable, contingency, continually, database, Debenture, deceleration, dedicated, degrade, delivered, device, discontinuance, division, dropout, drove, ECCO, Emerging, encountered, enterprise, essentially, estate, evaluable, exceeded, extracellular, extracellularly, failed, FAS, feline, FeLV, FIN, Flagship, force, France, front, Galenica, gastric, genomic, Genzyme, Goldman, GPC, gupta, half, halt, Hampshire, Harvard, ideal, implementation, indexed, inspect, integrated, intracellular, investigating, irinotecan, John, joined, joining, kill, leave, leukemia, likewise, marrow, maturing, MBA, McKinsey, mentioned, Merck, Mojave, Monica, Navin, Neuralab, NewcoGen, NG, Norway, noubar, Nventa, pancreatic, partnership, pivotal, played, Poniard, postpone, postponement, predictor, preliminary, Prestara, pretreated, principally, principle, prospective, protease, purification, Pvt, real, reclassified, recommendation, recoverable, reducing, reflection, refocused, refocusing, registrable, releasing, remained, remaining, remeasured, remeasurement, rendering, renu, represented, requested, responsive, retired, reveal, SAB, sample, Santa, science, secrecy, Shaman, significance, solvency, speed, spouse, Stressgen, submitting, sufficiency, suggested, systemic, Task, Techsoft, trader, training, trend, undergone, unforeseen, uninvested, unreliable, venture, Vice, Virbac, Washington, Wayne, worked, worth, youth
Filing tables
Filing exhibits
Related press release
AGEN similar filings
Filing view
External links
Exhibit 10.4.1
SCHEDULE TO INDEMNIFICATION AGREEMENT
The following is a list of the current and former directors and executive officers of Antigenics who are party to an Indemnification Agreement, the form of which was filed as Exhibit 10.4 to our registration statement on Form S-1 (File No. 333-91747):
Garo H. Armen, Ph.D.
Noubar Afeyan, Ph.D.
Frank V. AtLee III
John Cerio
Gamil G. de Chadarevian
Brian Corvese
Tom Dechaene
Margaret Eisen
Renu Gupta, MD
John Hatsopoulos
Wadih Jordan
Mark Kessel
Christine Klaskin
Bruce Leicher
Hyam Levitsky, MD
Steve Monks
Deanna Petersen
Timothy Rothwell
Shalini Sharp
Pramod K. Srivastava, Ph.D.
Peter Thornton
Karen Higgins Valentine
Kerry Wentworth
Alastair Wood, MD
Timothy R. Wright